1. Service Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for
Study
1.2.3. Key Market
Segmentations
2. Research Methodology
2.1. Objective of the
Study
2.2. Baseline Methodology
2.3. Key Industry
Partners
2.4. Major Association
and Secondary Sources
2.5. Forecasting
Methodology
2.6. Data Triangulation
& Validation
2.7. Assumptions and
Limitations
3. Executive Summary
3.1. Overview of the
Market
3.2. Overview of Key
Market Segmentations
3.3. Overview of Key
Market Players
3.4. Overview of Key
Regions/Countries
3.5. Overview of Market
Drivers, Challenges, and Trends
4. Voice of Customer
5.
Global Lung Cancer Therapeutics Market Outlook
5.1. Market Size &
Forecast
5.1.1. By Value
5.2. Market Share &
Forecast
5.2.1. By Cancer Cell Type (Non-small
Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC))
5.2.2. By Treatment (Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy,
Other Treatments)
5.2.3. By Region
5.2.4. By Company (2022)
5.3. Market Map
5.3.1. By Cancer Cell Type
5.3.2. By Treatment
6.
North America Lung Cancer Therapeutics Market Outlook
6.1. Market Size &
Forecast
6.1.1. By Value
6.2. Market Share &
Forecast
6.2.1. By Cancer Cell Type (Non-small
Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC)
6.2.2. By Treatment ( Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy,
Other Treatments)
6.2.3. By Country
6.3. North America:
Country Analysis
6.3.1. United States Lung
Cancer Therapeutics Market Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By Cancer
Cell Type
6.3.1.2.2.
By
Treatment
6.3.2. Canada Lung Cancer Therapeutics
Market Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By Cancer
Cell Type
6.3.2.2.2.
By
Treatment
6.3.3. Mexico Lung Cancer
Therapeutics Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By Cancer
Cell Type
6.3.3.2.2.
By Treatment
7.
Europe Lung Cancer Therapeutics Market Outlook
7.1. Market Size &
Forecast
7.1.1. By Value
7.2. Market Share &
Forecast
7.2.1. By Cancer Cell Type (Non-small
Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC)
7.2.2. By Treatment ( Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy,
Other Treatments)
7.2.3. By Country
7.3. Europe: Country
Analysis
7.3.1. France Lung Cancer
Therapeutics Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Cancer
Cell Type
7.3.1.2.2.
By
Treatment
7.3.2. Germany Lung Cancer Therapeutics
Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Cancer
Cell Type
7.3.2.2.2.
By
Treatment
7.3.3. United Kingdom Lung
Cancer Therapeutics Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Cancer
Cell Type
7.3.3.2.2.
By Treatment
7.3.4. Italy Lung Cancer
Therapeutics Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By Cancer
Cell Type
7.3.4.2.2.
By
Treatment
7.3.5. Spain Lung Cancer
Therapeutics Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By Cancer
Cell Type
7.3.5.2.2.
By
Treatment
8.
Asia-Pacific Lung Cancer Therapeutics Market Outlook
8.1. Market Size &
Forecast
8.1.1. By Value
8.2. Market Share &
Forecast
8.2.1. By Cancer Cell Type (Non-small
Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC)
8.2.2. By Treatment ( Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy,
Other Treatments)
8.2.3. By Country
8.3. Asia-Pacific:
Country Analysis
8.3.1. China Lung Cancer
Therapeutics Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Cancer
Cell Type
8.3.1.2.2.
By Treatment
8.3.2. Japan Lung Cancer
Therapeutics Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Cancer
Cell Type
8.3.2.2.2.
By
Treatment
8.3.3. India Lung Cancer
Therapeutics Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Cancer
Cell Type
8.3.3.2.2.
By
Treatment
8.3.4. South Korea Lung
Cancer Therapeutics Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Cancer
Cell Type
8.3.4.2.2.
By
Treatment
8.3.5. Australia Lung
Cancer Therapeutics Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Cancer
Cell Type
8.3.5.2.2.
By
Treatment
9.
South America Lung Cancer Therapeutics Market Outlook
9.1. Market Size &
Forecast
9.1.1. By Value
9.2. Market Share &
Forecast
9.2.1. By Cancer Cell Type (Non-small
Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC)
9.2.2. By Treatment ( Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy,
Other Treatments)
9.2.3. By Country
9.3. South America:
Country Analysis
9.3.1. Brazil Lung Cancer
Therapeutics Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Cancer
Cell Type
9.3.1.2.2.
By
Treatment
9.3.2. Argentina Lung
Cancer Therapeutics Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Cancer
Cell Type
9.3.2.2.2.
By
Treatment
9.3.3. Colombia Lung Cancer
Therapeutics Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Cancer
Cell Type
9.3.3.2.2.
By
Treatment
10.
Middle East and Africa Lung Cancer Therapeutics Market Outlook
10.1.
Market Size & Forecast
10.1.1. By Value
10.2.
Market Share & Forecast
10.2.1. By Cancer Cell Type (Non-small
Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC)
10.2.2. By Treatment ( Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy,
Other Treatments)
10.2.3. By Country
10.3.
MEA: Country Analysis
10.3.1. UAE Lung Cancer
Therapeutics Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1.
By Cancer
Cell Type
10.3.1.2.2.
By
Treatment
10.3.2. Saudi Arabia Lung
Cancer Therapeutics Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1.
By Cancer
Cell Type
10.3.2.2.2.
By
Treatment
10.3.3. South Africa Lung Cancer Therapeutics Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1.
By Cancer
Cell Type
10.3.3.2.2.
By
Treatment
10.3.4. Turkey Lung Cancer
Therapeutics Market Outlook
10.3.4.1. Market Size & Forecast
10.3.4.1.1.
By Value
10.3.4.2. Market Share & Forecast
10.3.4.2.1.
By Cancer
Cell Type
10.3.4.2.2.
By
Treatment
10.3.5. Egypt Lung Cancer
Therapeutics Market Outlook
10.3.5.1. Market Size & Forecast
10.3.5.1.1.
By Value
10.3.5.2. Market Share & Forecast
10.3.5.2.1.
By Cancer
Cell Type
10.3.5.2.2.
By
Treatment
11. Market Dynamics
11.1.
Drivers
11.1.1. Increasing
Prevalence of Lung Cancer.
11.1.2. Rise in the number
of Tobacco Smokers
11.1.3. Rise in demand for
Immunotherapy
11.2.
Challenges
11.2.1.
High Cost of Cancer Treatment
11.2.2. Side Effects of
Drugs
11.2.3. Lack of skilled
workforce
12. Market Trends &
Developments
12.1. Product Launches
12.2. Mergers &
Acquisitions
12.3. Technological
Advancements
13. Clinical Trial
Analysis
14. Global Lung Cancer
Therapeutics Market: SWOT Analysis
15. Competitive
Landscape
15.1. Business Overview
15.2. Product Offerings
15.3. Recent Developments
15.4. Financials (In Case
of Listed Companies)
15.5. Key Personnel
15.6. SWOT Analysis
15.6.1. AstraZeneca Plc
15.6.2. Boehringer Ingelheim
International GmbH.
15.6.3. Bristol-Myers Squibb
Company
15.6.4. Eli Lilly and
Company
15.6.5.
F. Hoffmann-La Roche Ltd.
15.6.6. Merck & Co
15.6.7. Pfizer Inc.
15.6.8. Allergan Inc.
15.6.9. Teva Pharmaceutical
Industries Ltd.
15.6.10. Abbvie, Inc.
15.6.11. Johnson &
Johnson
15.6.12. Amgen Inc.
15.6.13. Novartis AG
16. Strategic Recommendations